PCV69 CONVENIENCE OF THE NEW LONG-ACTING ANTICOAGULANT IDRAPARINUX VERSUS VITAMIN K ANTAGONIST IN PATIENTS WITH ATRIAL FIBRILLATION
Abstract
Authors
MH Prins P Leguet H Gilet A Roborel de Climens B Arnould
MH Prins P Leguet H Gilet A Roborel de Climens B Arnould
ISPOR recommends that you update your browser for more security, speed and the best experience on ispor.org. Update my browser now